Validation of AJCC TNM staging for breast tumors diagnosed before 2004 in cancer registries

Marilyn L. Kwan, Reina Haque, Valerie S. Lee, W. L Joanie Chung, Chantal C. Avila, Heather A. Clancy, Virginia P. Quinn, Lawrence H. Kushi

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Purpose American Joint Committee on Cancer (AJCC) Tumor (T), Nodal (N), and Metastatic (M) staging is commonly used in clinical practice for treatment decisions, yet before 2004, Surveillance Epidemiology and End Results (SEER)-affiliated cancer registries did not routinely include TNM staging defined by AJCC criteria, reporting instead SEER Summary Staging. Methods We developed and validated an algorithm to determine AJCC TNM staging from Extent of Disease information for 17,133 female breast cancer cases diagnosed from 1988 to 2003 in the cancer registries of Kaiser Permanente Northern and Southern California. Test characteristics (percent agreement, Cohen's kappa, sensitivity, specificity) were calculated to compare derived TNM with gold-standard TNM available in the registry. Results Agreement for TNM variables was excellent (range 0.91-1.00 for percent agreement and Cohen's kappa). The sensitivity and specificity, respectively, of the algorithm for AJCC TNM Version 6 staging were as follows: Stage 0 (0.99, 1.00), Stage I (0.97, 0.98), Stage II (0.91, 0.96), Stage III (0.69, 0.99), and Stage IV (0.92, 1.00). Stage III had lower sensitivity due to reclassification of supraclavicular lymph node positivity from M1 (Stage IV) to N3 (Stage IIIC) in AJCC Version 6. Conclusions Derived AJCC staging for breast tumors diagnosed before 2004 is feasible and accurate using cancer registry data.

Original languageEnglish (US)
Pages (from-to)1587-1591
Number of pages5
JournalCancer Causes and Control
Volume23
Issue number9
DOIs
StatePublished - Sep 2012
Externally publishedYes

Keywords

  • American Joint Committee on Cancer
  • Breast cancer
  • Cancer registry
  • Tumor, nodal, metastatic cancer staging
  • Validation study

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Validation of AJCC TNM staging for breast tumors diagnosed before 2004 in cancer registries'. Together they form a unique fingerprint.

  • Cite this

    Kwan, M. L., Haque, R., Lee, V. S., Chung, W. L. J., Avila, C. C., Clancy, H. A., Quinn, V. P., & Kushi, L. H. (2012). Validation of AJCC TNM staging for breast tumors diagnosed before 2004 in cancer registries. Cancer Causes and Control, 23(9), 1587-1591. https://doi.org/10.1007/s10552-012-0026-7